Removal of Electrophilic Potential Genotoxic Impurities Using Nucleophilic Reactive Resins
摘要:
Potential genotoxic impurities (PGI) are chemical compounds that could potentially damage DNA and lead to mutation. Controlling the occurrence of PGIs in active pharmaceutical ingredients (APIs) poses a big challenge for chemists, as levels of these compounds must be reduced well below the amounts required for other types of less toxic impurities. In situations where formation of PGIs cannot be avoided, an ideal solution would allow the complete removal of PGIs after the synthesis is complete, for example, by recrystallization, preparative chromatography or other downstream processing approaches. Some disadvantages of using these approaches are potential high yield loss, high solvent consumption, and additional time and resources required for process development. In this work, we present a simple and rapid approach to remove electrophilic PGIs from APIs. A selected nucleophilic resin can be added to the final API solution to reduce or totally remove the PGI. Esters of methanesulfonic acid (MSA), benzenesulfonic acid (BSA), and p-toluenesulfonic acid (pTSA) were used as model electrophilic PGIs. Several nucleophilic resins were screened, and the resins with the highest efficiency of PGI removal were chosen. A recommended procedure is presented for the removal of MSA, BSA, and pTSA esters. The kinetics of PGI removal, resin loading capacity, solvent effects, and API matrix effects are demonstrated.
shell, increasing the energy of the reaction (ca. 1 kJ·mol−1). The obtained results suggest the same kinetic mechanism of solvolysis of arenesulfonyl chlorides for propan‐1‐ol and propan‐2‐ol, as in MeOH and EtOH, where bimolecular nucleophilic substitution (SN2) takes place with nucleophilic solvent assistance of one alcohol molecule and the participation of the solvent network involving solvent molecules
A novel method for the preparation of 2,6-disubstituted benzenesulfonates and benzenesulfonyl chlorides utilizing the powerful alkyl sulfonate ortho directing group
作者:Lori A. Spangler
DOI:10.1016/0040-4039(96)00667-3
日期:1996.5
Ortho lithiation technology using alkylbenzenesulfonates has been developed to prepare a series of 2,6-disubstitutedbenzenesulfonates, benzenesulfonic acids and benzenesulfonylchlorides. By comparison with other orthodirectinggroups, alkylsulfonates are very powerful, leading to excellent regioselectivity.
Studies on chemical carcinogens and mutagens. XXV. Chemoselectivity of alkyl sulfonates toward 4-(p-nitrobenzyl)pyridine (NBP) in phosphate buffer.
作者:SHINICHI NINOMIYA、KOHFUKU KOHDA、YUTAKA KAWAZOE
DOI:10.1248/cpb.32.1326
日期:——
Methyl, ethyl, and isopropyl esters of six alkanesulfonic acids and five p-substituted benzenesulfonic acids were synthesized and their alkylating abilities were evaluated in terms of the chemoselectivity toward 4-(p-nitrobenzyl) pyridine (NBP) in phosphate buffer (pH 6.0) containing 60% acetone. The chemoselectivity constant toward NBP, SNBP, was defined as the logarithm of the ratio of the molar fraction of an alkylating sulfonate which is consumed for alkylation of NBP versus the molar fraction of the residual alkylating agent which is hydrolyzed in the buffer medium. It was found that SNBP was not only markedly dependent on the structure of the alkyl moiety of the molecule, but also appreciably dependent on the electronic nature of the leaving sulfonic acid moiety. The structure-chemoselectivity relationship is discussed.
Alkylation of enamines of bis(ethylthio)acetaldehyde: synthesis of norpyrenophorin
作者:Gordon S. Bates、S. Ramaswamy
DOI:10.1039/c39800000904
日期:——
Alkylation of the potassium anion of the glyoxal derivatives (4) with halides and sulphonate esters, followed by acidic hydrolysis, provides good yields of the corresponding pyruvaldehyde α-thioacetals.
作者:Kaitlyn Corazzata、Peter J. Rose、Shunyan Mo、Joseph Snodgrass、Alexander Langston、Elaine C. Lee
DOI:10.1021/acs.oprd.1c00335
日期:2022.3.18
presence of alkylsulfonates, which were identified as potential genotoxic impurities in our active pharmaceutical ingredient (API). As a result, we initiated a development effort to identify a method to remove the alkylsulfonates that would be amenable for scale-up. Herein, we report our effort toward the development of a general approach using DABCO (1,4-diazabicyclo[2.2.2]octane) to remove alkyl sulfonates